CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,443,671 | +21.0% | 44,448 | +1.5% | 0.04% | +14.7% |
| Q3 2023 | $1,193,522 | +4516.2% | 43,807 | +3670.0% | 0.03% | +3300.0% |
| Q2 2023 | $25,855 | +0.7% | 1,162 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $25,667 | +4.2% | 1,185 | -2.3% | 0.00% | 0.0% |
| Q4 2022 | $24,636 | -25.3% | 1,213 | -5.6% | 0.00% | 0.0% |
| Q3 2022 | $33,000 | +22.2% | 1,285 | +14.3% | 0.00% | 0.0% |
| Q2 2022 | $27,000 | +17.4% | 1,124 | +8.1% | 0.00% | – |
| Q1 2022 | $23,000 | -95.9% | 1,040 | -96.3% | 0.00% | -100.0% |
| Q4 2021 | $562,000 | +4.1% | 28,365 | +3.4% | 0.01% | -21.4% |
| Q3 2021 | $540,000 | -34.1% | 27,438 | -26.4% | 0.01% | -46.2% |
| Q2 2021 | $820,000 | +3.8% | 37,279 | +12.3% | 0.03% | -13.3% |
| Q1 2021 | $790,000 | -23.7% | 33,190 | -16.2% | 0.03% | -37.5% |
| Q4 2020 | $1,036,000 | +66.6% | 39,591 | +10.9% | 0.05% | +37.1% |
| Q3 2020 | $622,000 | -1.6% | 35,715 | -5.0% | 0.04% | -66.7% |
| Q2 2020 | $632,000 | – | 37,601 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |